Artificial Intelligence in Basel and in Switzerland
Panel discussion at the BioData World Congress
What are the implications of a globally accelerating AI innovation for Basel and Switzerland? That was the key question at the BioData World Congress Basel. Together with the other panelists Bram Stieltjes (University Hospital Basel), Hans-Peter Frank (Global Head eHealth Ventures, Vifor Pharma) and Ralf Dümpelmann (Baselarea.swiss), Kai Gramke from EconSight discussed the opportunities and risks for Basel as a health location. The excerpt from the presentation above shows Roche’s outstanding role in bioinformatics/big data/artificial intelligence, but also the dynamics and activities of smaller companies and large IT companies in the healthcare sector.